Many people are swept up in buying gifts for their loved ones this time of year, but you can't forget to wrap up your financial obligations! Chris Hogan, Financial Expert and Author of "Retire Inspired", joins Your Cheddar to discuss what you need to do before the ball drops to ring in the new year.
Hogan says it's important to take a look at any leftover money from your 2017 budget and look at retirement options. You may still have time to increase your 401(k) contribution and consider contributing your yearly bonus toward retirement.
Plus, how certain states will be impacted by the Senate passing its tax reform bill. Hogan advises people to make sure all their paperwork is in order so they hit any end-of-the-year deadlines.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
